Rational Combinations 360° is a comprehensive program providing exposure to the entire spectrum of research and development, addressing key aspects across all facets of combination immunotherapies. It covers business positions, clinical advancements, and scientific data in IO combination strategies to fight a wider range of cancers.
The program is designed for all size pharma/biotech companies and investors seeking to accelerate clinical trials in the emerging immuno-oncology space.
Lead advisors
- Dr. Patrick Hwu (MD Anderson)
- Dr. Axel Hoos (GSK)
- Dr. Ian McCaffery (Janssen)
Photo by Leo SERRAT on Unsplash
